Elan Corporation, plc (ELN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (3443)	10/27/2002 5:54:56 PM
From: Icebrg	Read Replies (1) of 10345

Rick >>I presume that you know this......>> Well, I used to be an accountant, so this is fairly unknown stuff for me. Many thanks for your efforts. It will give me impetus to look further into the basics of these reactions. It's very good to know where to look. After Armen's indication that he is going to slim down the company to its "absolute minimum", they will be even more dependent on Antegren success. (The LYONs are not an issue any more, IMHO). Sales @ 500 mUSD should be OK, but if they lose Skelaxin to the generic side, they will become very vulnerable. Unless investors feel that they have a good reason to look forward to positive news from Antegren. The rest of the short- to medium-term pipe seems rather empty to me. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next